Single-cell Transcriptomic Sequencing Data Reveal Aberrant DNA Methylation in SMAD3 Promoter Region in Tumor-associated Fibroblasts Affecting Molecular Mechanism of Radiosensitivity in Non-small Cell Lung Cancer

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2024 Mar 17

PMID 38493128

Authors

Fushi Han

Shuzhen Chen

Kangwei Zhang

Kunming Zhang

Meng Wang

Peijun Wang

Affiliations

Soon will be listed here.

Abstract

Objective: Non-small cell lung cancer (NSCLC) often exhibits resistance to radiotherapy, posing significant treatment challenges. This study investigates the role of SMAD3 in NSCLC, focusing on its potential in influencing radiosensitivity via the ITGA6/PI3K/Akt pathway.

Methods: The study utilized gene expression data from the GEO database to identify differentially expressed genes related to radiotherapy resistance in NSCLC. Using the GSE37745 dataset, prognostic genes were identified through Cox regression and survival analysis. Functional roles of target genes were explored using Gene Set Enrichment Analysis (GSEA) and co-expression analyses. Gene promoter methylation levels were assessed using databases like UALCAN, DNMIVD, and UCSC Xena, while the TISCH database provided insights into the correlation between target genes and CAFs. Experiments included RT-qPCR, Western blot, and immunohistochemistry on NSCLC patient samples, in vitro studies on isolated CAFs cells, and in vivo nude mouse tumor models.

Results: Fifteen key genes associated with radiotherapy resistance in NSCLC cells were identified. SMAD3 was recognized as an independent prognostic factor for NSCLC, linked to poor patient outcomes. High expression of SMAD3 was correlated with low DNA methylation in its promoter region and was enriched in CAFs. In vitro and in vivo experiments confirmed that SMAD3 promotes radiotherapy resistance by activating the ITGA6/PI3K/Akt signaling pathway.

Conclusion: High expression of SMAD3 in NSCLC tissues, cells, and CAFs is closely associated with poor prognosis and increased radiotherapy resistance. SMAD3 is likely to enhance radiotherapy resistance in NSCLC cells by activating the ITGA6/PI3K/Akt signaling pathway.

Citing Articles

STAT1 increases the sensitivity of lung adenocarcinoma to carbon ion irradiation via HO-1-mediated ferroptosis.

Chen Y, Wang D, Luo H, Tan M, Wang Q, Wu X Mol Cell Biochem. 2025; .

PMID: 40087208 DOI: 10.1007/s11010-025-05240-z.

Construction of a novel radioresistance-related signature for prediction of prognosis, immune microenvironment and anti-tumour drug sensitivity in non-small cell lung cancer.

Chen Y, Zhou C, Zhang X, Chen M, Wang M, Zhang L Ann Med. 2025; 57(1):2447930.

PMID: 39797413 PMC: 11727174. DOI: 10.1080/07853890.2024.2447930.

Identification of ALDH7A1 as a DNA-methylation-driven gene in lung squamous cell carcinoma.

Liang G, He J, Chen T, Zhang L, Yu K, Shen W Ann Med. 2024; 57(1):2442529.

PMID: 39711312 PMC: 11703541. DOI: 10.1080/07853890.2024.2442529.

Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment.

Raaijmakers K, Adema G, Bussink J, Ansems M J Exp Clin Cancer Res. 2024; 43(1):323.

PMID: 39696386 PMC: 11658324. DOI: 10.1186/s13046-024-03251-0.

TGM2-Mediated Autophagy Contributes to the Radio-Resistance of Non-Small Cell Lung Cancer Stem-like Cells.

Wang Q, Zhang Q, Wang X, Luo H, Du T, Wu L Biomedicines. 2024; 12(10).

PMID: 39457544 PMC: 11504678. DOI: 10.3390/biomedicines12102231.

References

Liu B, Liu H, Ma Y, Ding Q, Zhang M, Liu X . EGFR-mutated stage IV non-small cell lung cancer: What is the role of radiotherapy combined with TKI?. Cancer Med. 2021; 10(18):6167-6188. PMC: 8446557. DOI: 10.1002/cam4.4192. View

Hu T, Zhou R, Zhao Y, Wu G . Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy. Sci Rep. 2016; 6:33376. PMC: 5022055. DOI: 10.1038/srep33376. View

Zhu W, Li Y, Zhao J, Wang Y, Li Y, Wang Y . The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking. Ann Med. 2022; 54(1):541-552. PMC: 8843192. DOI: 10.1080/07853890.2022.2034931. View

Borodins O, Broghammer F, Seifert M, Cordes N . Meta-analysis of expression and the targeting of cell adhesion associated genes in nine cancer types - A one research lab re-evaluation. Comput Struct Biotechnol J. 2023; 21:2824-2836. PMC: 10189096. DOI: 10.1016/j.csbj.2023.04.017. View

Bamodu O, Chang H, Ong J, Lee W, Yeh C, Tsai J . Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma. Cells. 2020; 9(3). PMC: 7140693. DOI: 10.3390/cells9030746. View

Huang W, Zhang L, Yang M, Wu X, Wang X, Huang W . Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-κB pathway. J Exp Clin Cancer Res. 2021; 40(1):87. PMC: 7923322. DOI: 10.1186/s13046-021-01878-x. View

Guo G, Tan Z, Liu Y, Shi F, She J . The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer. Stem Cell Res Ther. 2022; 13(1):138. PMC: 8973885. DOI: 10.1186/s13287-022-02811-5. View

Guo X, Zhu R, Luo A, Zhou H, Ding F, Yang H . EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability. J Exp Clin Cancer Res. 2020; 39(1):175. PMC: 7457539. DOI: 10.1186/s13046-020-01678-9. View

Zhou C, Wei W, Ma J, Yang Y, Liang L, Zhang Y . Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels. Mol Ther. 2021; 29(4):1512-1528. PMC: 8058488. DOI: 10.1016/j.ymthe.2020.12.034. View

10.

Meng J, Li Y, Wan C, Sun Y, Dai X, Huang J . Targeting senescence-like fibroblasts radiosensitizes non-small cell lung cancer and reduces radiation-induced pulmonary fibrosis. JCI Insight. 2021; 6(23). PMC: 8675198. DOI: 10.1172/jci.insight.146334. View

11.

Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J . Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020; 5(1):8. PMC: 7005297. DOI: 10.1038/s41392-020-0110-5. View

12.

Duan M, Fang M, Wang C, Wang H, Li M . LncRNA EMX2OS Induces Proliferation, Invasion and Sphere Formation of Ovarian Cancer Cells via Regulating the miR-654-3p/AKT3/PD-L1 Axis. Cancer Manag Res. 2020; 12:2141-2154. PMC: 7102881. DOI: 10.2147/CMAR.S229013. View

13.

Liao J, Chen Z, Yu Z, Huang T, Hu D, Su Y . The Role of in Erlotinib Resistance: Activation of the //β- Signaling Pathway. Front Oncol. 2020; 10:585292. PMC: 7657464. DOI: 10.3389/fonc.2020.585292. View

14.

Icard P, Simula L, Fournel L, Leroy K, Lupo A, Damotte D . The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications. Drug Resist Updat. 2022; 63:100852. DOI: 10.1016/j.drup.2022.100852. View

15.

Zhang H, Hua Y, Jiang Z, Yue J, Shi M, Zhen X . Cancer-associated Fibroblast-promoted LncRNA Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma. Clin Cancer Res. 2018; 25(6):1989-2000. DOI: 10.1158/1078-0432.CCR-18-0773. View

16.

Ellert-Miklaszewska A, Poleszak K, Pasierbinska M, Kaminska B . Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy. Int J Mol Sci. 2020; 21(3). PMC: 7037280. DOI: 10.3390/ijms21030888. View

17.

Marwitz S, Ballesteros-Merino C, Jensen S, Reck M, Kugler C, Perner S . Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer. J Immunother Cancer. 2021; 9(2). PMC: 7887360. DOI: 10.1136/jitc-2020-001469. View

18.

Qiu Z, Zhu W, Meng H, Tong L, Li X, Luo P . CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter. Theranostics. 2019; 9(16):4717-4729. PMC: 6643436. DOI: 10.7150/thno.33680. View

19.

Berzaghi R, Tornaas S, Lode K, Hellevik T, Martinez-Zubiaurre I . Ionizing Radiation Curtails Immunosuppressive Effects From Cancer-Associated Fibroblasts on Dendritic Cells. Front Immunol. 2021; 12:662594. PMC: 8221608. DOI: 10.3389/fimmu.2021.662594. View

20.

He J, Huang Z, Han L, Gong Y, Xie C . Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review). Int J Oncol. 2021; 59(5). PMC: 8562388. DOI: 10.3892/ijo.2021.5270. View